Peptides immunoreactifs du papillomavirus humain

Human papilloma virus immunoreative peptides

Abstract

La présente invention concerne des peptides immunogènes issus de la protéine HPV-18E6 qui comprend des épitopes de lymphocyte T de la classe I restreinte, des techniques d'administration de ces peptides à des personnes ainsi qu'une technique de surveillance ou d'évaluation d'une réponse immune au HPV avec ces peptides.
This invention provides immunogenic peptides from the HPV-18E6 protein that comprise class I restricted T cell epitopes and discloses methods of administering these peptides to individuals, and a method for monitoring or evaluating an immune response to HPV with these peptides.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (5)

    Title
    MCLAIN ET AL.: "Different effects of a single amino acid substitution of three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1", ARCH VIROL, vol. 146, 2001, pages 157 - 166
    RESSING ET AL.: "Human CTL Epitopes Encoded by Human Papillomavirus Type 16 E6 and E7 Identified Through In Vivo and In Vitro Immunogenicity Studies of HLA-A*0201-Binding Peptides", JOURNAL OF IMMUNOLOGY, vol. 154, 1995, pages 5934 - 5943
    RUDOLF ET AL., CLINICAL CANCER RESEARCH, vol. 7, no. 3, 1 March 2001 (2001-03-01), pages 788S - 795S
    See also references of EP 1425039A4
    TAKAHASHI ET AL.: "A single amino acid interchange yields reciprocal CTL specificities for HIV gp160", SCIENCE, vol. 286, 1989, pages 118 - 121

Cited By (9)

    Publication numberPublication dateAssigneeTitle
    US-7541035-B2June 02, 2009The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesImmunogenic peptides for the treatment of prostate and breast cancer
    US-7691579-B2April 06, 2010The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesMethods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
    US-8043623-B2October 25, 2011The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesImmunogenic peptides for the treatment of prostate and breast cancer
    WO-2005000889-A1January 06, 2005The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesPeptides immunogenes utiles dans le traitement du cancer de la prostate et du cancer du sein
    WO-2006113209-A1October 26, 2006The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicesProcedes et compositions permettant de produire une reponse immunitaire amelioree contre un immunogene papillomavirus humain
    WO-2007121894-A2November 01, 2007Transgene S.A.Vaccin contre le papillomavirus à base de hpv-18
    WO-2007121894-A3March 20, 2008Stephane Paul, Ronald Rooke, Transgene SaHpv-18-based papillomavirus vaccine
    WO-2007121895-A2November 01, 2007Transgene S.A.Vaccin contre le papillomavirus
    WO-2007121895-A3March 20, 2008Transgene Sa, Ronald Rooke, Stephane PaulVaccin contre le papillomavirus